Logo image of NRM.CA

NORAM LITHIUM CORP (NRM.CA) Stock Fundamental Analysis

TSX-V:NRM - CA65542K1030 - Common Stock

0.095 CAD
0 (0%)
Last: 8/29/2025, 7:00:00 PM
Fundamental Rating

0

NRM gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 803 industry peers in the Metals & Mining industry. NRM may be in some trouble as it scores bad on both profitability and health. NRM is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

NRM had negative earnings in the past year.
NRM had a negative operating cash flow in the past year.
In the past 5 years NRM always reported negative net income.
In the past 5 years NRM always reported negative operating cash flow.
NRM.CA Yearly Net Income VS EBIT VS OCF VS FCFNRM.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -2M -4M -6M -8M

1.2 Ratios

NRM has a worse Return On Assets (-53.03%) than 64.13% of its industry peers.
NRM has a Return On Equity (-59.83%) which is in line with its industry peers.
Industry RankSector Rank
ROA -53.03%
ROE -59.83%
ROIC N/A
ROA(3y)-50.07%
ROA(5y)-67.78%
ROE(3y)-53.46%
ROE(5y)-73.08%
ROIC(3y)N/A
ROIC(5y)N/A
NRM.CA Yearly ROA, ROE, ROICNRM.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -100 -200 -300

1.3 Margins

NRM does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NRM.CA Yearly Profit, Operating, Gross MarginsNRM.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

More info and screens

1

2. Health

2.1 Basic Checks

Compared to 1 year ago, NRM has more shares outstanding
NRM has more shares outstanding than it did 5 years ago.
NRM has a worse debt/assets ratio than last year.
NRM.CA Yearly Shares OutstandingNRM.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
NRM.CA Yearly Total Debt VS Total AssetsNRM.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M

2.2 Solvency

NRM has an Altman-Z score of 0.20. This is a bad value and indicates that NRM is not financially healthy and even has some risk of bankruptcy.
NRM has a Altman-Z score (0.20) which is in line with its industry peers.
NRM has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
NRM has a Debt to Equity ratio (0.02) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z 0.2
ROIC/WACCN/A
WACCN/A
NRM.CA Yearly LT Debt VS Equity VS FCFNRM.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M 10M

2.3 Liquidity

NRM has a Current Ratio of 0.91. This is a bad value and indicates that NRM is not financially healthy enough and could expect problems in meeting its short term obligations.
NRM has a worse Current ratio (0.91) than 60.40% of its industry peers.
NRM has a Quick Ratio of 0.91. This is a bad value and indicates that NRM is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.91, NRM perfoms like the industry average, outperforming 41.97% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.91
Quick Ratio 0.91
NRM.CA Yearly Current Assets VS Current LiabilitesNRM.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 40.65% over the past year.
EPS 1Y (TTM)40.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-18.87%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

NRM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NRM.CA Price Earnings VS Forward Price EarningsNRM.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NRM.CA Per share dataNRM.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 0.04 0.06

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NRM!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NORAM LITHIUM CORP

TSX-V:NRM (8/29/2025, 7:00:00 PM)

0.095

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)06-30 2025-06-30
Earnings (Next)09-29 2025-09-29
Inst Owners5.8%
Inst Owner ChangeN/A
Ins Owners8.42%
Ins Owner ChangeN/A
Market Cap8.50M
Analysts84.44
Price Target1.16 (1121.05%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.57
P/tB 1.57
EV/EBITDA N/A
EPS(TTM)-0.04
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0
BVpS0.06
TBVpS0.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -53.03%
ROE -59.83%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-50.07%
ROA(5y)-67.78%
ROE(3y)-53.46%
ROE(5y)-73.08%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 767.51%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.91
Quick Ratio 0.91
Altman-Z 0.2
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)3838.09%
Cap/Depr(5y)2641.43%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)40.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-18.87%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y46.04%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y56.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y49.41%
OCF growth 3YN/A
OCF growth 5YN/A